Introduction Imagine that you are a founder of a revolutionary technology startup in Canada. Your company is about to release its blockbuster product that will disrupt the entire industry and…
Attorney Mauricio Uribe authored “Resolving AV ownership and licensing issues,” which was published in Autonomous Vehicle Technology. Excerpt: Since the first semi-autonomous Navlab and ALV vehicles emerged from Carnegie Mellon University in the…
Attorney Ed Schlatter authored “Protecting Offshore Production Innovations,” which was published in Offshore Engineer. Excerpt: Congratulations! You’ve just redesigned the subsea isolation valve control system (SSIV) that your company sells for use as…
On March 2, 2020, the Federal Circuit issued Comcast v. ITC and held that the International Trade Commission (ITC) can block the importation of products that do not infringe a U.S. patent…
Radhika Raman and Stephen Larson authored “FTC Impact Study on State Hospital Mergers to Consider Role of Certificates of Public Advantage (“COPA”)” which was published in AIPLA IP Antitrust News. Read the full…
Attorney Brian Reece authored “Distinctiveness of Marks Suffering Genericide: A Survey of Genericide Cases,” which was published in AIPLA Quarterly Journal. Excerpt: Genericide occurs when a trademark becomes the generic term for a…
Attorneys Susan Natland, Lynda Zadra-Symes and Of Counsel Arsen Kourinian authored “How High Court May Resolve Generic’.Com’ TM Issue,” which was published in Law360. Excerpt: On Nov. 8, the U.S. Supreme Court…
The Court of Appeals for the Federal Circuit (“Federal Circuit”) has issued an important decision affecting inter partes review (“IPR”) and possibly other cases decided by the Patent Trial and Appeal Board…
Daniel Hughes and Stephen Larson authored “IP Antitrust News: Xitronix v. KLA-Tencor: The Federal Circuit Finally Ends A Game Of Jurisdictional Hot Potato” which was published in IP Antitrust News….
Attorneys Jonathan Bachand and William Adams co-authored “What Celgene Corp. v. Peter Means For Biosimilar Developers,” which was published on the Biosimilar Development website. Excerpt: A recent decision by the U.S….
